Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
12:09:47 EDT Tue 25 Aug 2026
Enter Symbol
or Name
USA
CA



Q:CPIX - CUMBERLAND PHARMACEUTICALS INC - https://www.cumberlandpharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CPIX - Q2.78.26·8.340.68.3109+0.47096.019.81453567.855  8.4521  7.638.45  1.8511:51:29Aug 0415 min RT 2¢

Recent Trades - Last 10 of 356
Time ETExPriceChangeVolume
11:51:29Q8.330.495
11:51:29Q8.320.482
11:50:46Q8.320.4832
11:49:06Q8.330.495
11:49:06Q8.330.498
11:47:55Q8.33720.49721
11:45:45Q8.330.4932
11:44:19Q8.330.491
11:43:12Q8.330.4953
11:42:32Q8.270.431

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-08-04 17:06U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS REPORTS COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
2026-07-28 16:05U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
2026-07-13 11:20U:CPIXNews Release/C O R R E C T I O N -- Cumberland Pharmaceuticals Inc./
2026-07-13 10:46U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE
2026-07-01 09:00U:CPIXNews ReleaseCumberland Pharmaceuticals Closes Strategic Transaction with Apotex
2026-06-26 11:00U:CPIXNews ReleaseCumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference
2026-06-02 09:05U:CPIXNews ReleaseCumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis
2026-05-28 09:05U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV(TM) IN CHINA
2026-05-05 17:00U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
2026-04-28 16:05U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
2026-04-23 09:00U:CPIXNews ReleaseCumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex
2026-04-22 08:00U:CPIXNews ReleaseRedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026
2026-04-16 09:05U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLOR(TM) (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE
2026-03-17 09:05U:CPIXNews ReleaseCumberland Pharmaceuticals Launches New Sancuso(TM) Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting
2026-03-03 17:00U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH
2026-02-25 07:00U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA(TM)
2026-02-25 07:00U:CPIXNews ReleaseJoint U.S. Commercialization of RedHill's Talicia(TM) Commences
2026-02-24 16:05U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE
2026-02-04 09:05U:CPIXNews ReleaseCumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program
2025-12-08 09:05U:CPIXNews ReleaseCALDOLOR(TM) (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT